MedTrace Logo

Lot-to-lot Consistency of Sci-B-Vac™ in Adults

NCT03408730 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2838

Last updated 2021-03-25

Study results available
· View outcomes & findings →

Summary

A Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults

Conditions

  • Hepatitis B Vaccines

Interventions

BIOLOGICAL

Hepatitis B Vaccination

Hepatitis B Vaccination

Sponsors & Collaborators

  • VBI Vaccines Inc.

    lead INDUSTRY

Principal Investigators

  • Francisco Diaz-Mitoma, MD, PhD · VBI Vaccines

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2019-10-01
Completion
2019-10-01
FDA Drug
Yes

Countries

  • United States
  • Belgium
  • Canada
  • Finland
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03408730 on ClinicalTrials.gov